© 1991 Oxford University Press
research-article |
Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon
Nestec Ltd, Nestlé Research Centre CH-1000, Vers-chez-les Blanc, Lausanne 26. Switzerland
1John L.McClellan Veterans' Administration Hospital Little Rock, AR 72205 USA
2National Center for Toxicological Research Jefferson, AR 72079, USA
The metabolic activation of the food-borne rodent carcinogens 2-amino-3-methylimidazo [4,5-f]quinoline (IQ), 2-amino-3,8-dimethylimidazo [4,5-f]quinoline (MeIQx), 2-amino-1-methyl-6-phenylimidazo[4,5-bpyridine (PhIP) and 2-amino-6-methyldlpyrido{1 ,2-a :3' ,2'-d]imidazole (Glu-P-1) was compared with that of the known human carcinogen 4-aminobiphenyl (ABP), using human liver microsomes, human and rat liver cytosols, and human colon cytosol. All of these aromatic amines were readily activated by N-hydroxylation with human liver microsomes (2.3–5.3 nmol/min/mg protein), with PhIP and ABP exhibiting the highest rates of cytochrome P450IA2-dependent N-oxidation, followed by MeIQ IQ and Glu-P-1. In contrast, while ABP and 2-aminofluorene were readily N-acetylated (1.7–2.3 nmol/min/mg protein) by the polymorphic human liver cytosolic N-acetyltransferase, none of the heterocyclic amines were detectable as substrates (<0.05 mnol/min/mg protein). Likewise, only low activity was observed (0.11 nmol/min/mg protein) for the N-acetylation of p-aminobenzoic acid, a selective substrate for the human monomorphic liver N-acetyl-transferase. The radiolabeled N-hydroxy (N-OH) arylamine metabolites were synthesized and their reactivity with DNA was examined. Each derivative bound covalently with DNA at neutral pH (7.0), with highest levels of binding observed for N-OH-IQ and N-OH-PhIP. Incubation at acidic pH (5.0) resulted in increased levels of DNA binding, suggesting formation of reactive arylnitrenium ion intermediates. These N-OH arylamines were further activated to DNA-bound products by human hepatic O-acetyltransferase. Acetyl coenzyme A (AcC0A)-dependent, cytosol-catalyzed DNA binding was greatest for N-OH-ABP and N-OH-Glu-P-1, followed by N-OH-PhIP, N-OH-MeIQx and N-OH-IQ; and both rapid and slow acetylator phenotypes were apparent. Rat liver cytosol also catalyzed AcCoA-dependent DNA binding of the N-OH arylamines; and substrate specificities were comparable to human liver, except that N-OH-MeIQ and N-OH-PhIP gave relatively higher and lower activities respectively. Human colon cytosols likewise displayed AcCoA dependent DNA binding activity for the N-OH substrates. Metabolic activity was generally lower than that found with the rapid acetylator liver cytosols; however, substrate specificity was variable and phenotypic differences in colon
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  V. M. Lakshmi, F.-F. Hsu, and T. V. Zenser Identification of New 2-Amino-3-methylimidazo[4,5-f]quinoline Urinary Metabolites from {beta}-Naphthoflavone-Treated Mice Drug Metab. Dispos., August 1, 2009; 37(8): 1690 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Lakshmi, F. F. Hsu, and T. V. Zenser N-Demethylation Is a Major Route of 2-Amino-3-Methylimidazo[4,5-f]quinoline Metabolism in Mouse Drug Metab. Dispos., June 1, 2008; 36(6): 1143 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shin, M. J. Shrubsole, J. M. Rice, Q. Cai, M. A. Doll, J. Long, W. E. Smalley, Y. Shyr, R. Sinha, R. M. Ness, et al. Meat Intake, Heterocyclic Amine Exposure, and Metabolizing Enzyme Polymorphisms in Relation to Colorectal Polyp Risk Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 320 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Husain, X. Zhang, M. A. Doll, J. C. States, D. F. Barker, and D. W. Hein Identification of N-Acetyltransferase 2 (NAT2) Transcription Start Sites and Quantitation of NAT2-Specific mRNA in Human Tissues Drug Metab. Dispos., May 1, 2007; 35(5): 721 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Tang, J. J. Liu, A. Rundle, C. Neslund-Dudas, A. T. Savera, C. H. Bock, N. L. Nock, J. J. Yang, and B. A. Rybicki Grilled Meat Consumption and PhIP-DNA Adducts in Prostate Carcinogenesis Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 803 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Obligacion, M. Murray, and I. Ramzan Drug-Metabolizing Enzymes and Transporters: Expression in the Human Prostate and Roles in Prostate Drug Disposition J Androl, March 1, 2006; 27(2): 138 - 150. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Humblot, B. Combourieu, M.-L. Vaisanen, J.-P. Furet, A.-M. Delort, and S. Rabot 1H Nuclear Magnetic Resonance Spectroscopy-Based Studies of the Metabolism of Food-Borne Carcinogen 2-Amino-3-Methylimidazo[4,5-f]Quinoline by Human Intestinal Microbiota Appl. Envir. Microbiol., September 1, 2005; 71(9): 5116 - 5123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Pool-Zobel, V. Selvaraju, J. Sauer, T. Kautenburger, J. Kiefer, K. K. Richter, M. Soom, and S. Wolfl Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics Carcinogenesis, June 1, 2005; 26(6): 1064 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nishikawa, T. Imazawa, Y. Kuroiwa, Y. Kitamura, K. Kanki, Y. Ishii, T. Umemura, and M. Hirose Induction of Colon Tumors in C57BL/6J Mice Fed MeIQx, IQ, or PhIP Followed by Dextran Sulfate Sodium Treatment Toxicol. Sci., April 1, 2005; 84(2): 243 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-i. Masumura, Y. Totsuka, K. Wakabayashi, and T. Nohmi Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse Carcinogenesis, December 1, 2003; 24(12): 1985 - 1993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. de Jong, I. M. Nolte, G. J. te Meerman, W. T. A. van der Graaf, E. G. E. de Vries, R. H. Sijmons, R. M. W. Hofstra, and J. H. Kleibeuker Low-penetrance Genes and Their Involvement in Colorectal Cancer Susceptibility Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1332 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.G. Stillwell, R. Sinha, and S.R. Tannenbaum Excretion of the N2-glucuronide conjugate of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in urine and its relationship to CYP1A2 and NAT2 activity levels in humans Carcinogenesis, May 1, 2002; 23(5): 831 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Langouet, A. Paehler, D. H. Welti, N. Kerriguy, A. Guillouzo, and R. J. Turesky Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rat and human hepatocytes Carcinogenesis, January 1, 2002; 23(1): 115 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Le Marchand, J. H. Hankin, L. R. Wilkens, L. M. Pierce, A. Franke, L. N. Kolonel, A. Seifried, L. J. Custer, W. Chang, A. Lum-Jones, et al. Combined Effects of Well-done Red Meat, Smoking, and Rapid N-Acetyltransferase 2 and CYP1A2 Phenotypes in Increasing Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1259 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.-L. Steffensen, H. A. J. Schut, J. E. Paulsen, A. Andreassen, and J. Alexander Intestinal Tumorigenesis in Multiple Intestinal Neoplasia Mice Induced by the Food Mutagen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: Perinatal Susceptibility, Regional Variation, and Correlation with DNA Adducts Cancer Res., December 1, 2001; 61(24): 8689 - 8696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Allen, L. Mueller, S. N. Williams, L. C. Quattrochi, and J. Raucy The Use of a High-Volume Screening Procedure to Assess the Effects of Dietary Flavonoids on Human CYP1A1 Expression Drug Metab. Dispos., August 1, 2001; 29(8): 1074 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-F. Yueh, N. Nguyen, M. Famourzadeh, C. P. Strassburg, Y. Oda, F.P. Guengerich, and R. H. Tukey The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines Carcinogenesis, June 1, 2001; 22(6): 943 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Nelson, L. C. R. Kidd, J. Sauvageot, W. B. Isaacs, A. M. De Marzo, J. D. Groopman, W. G. Nelson, and T. W. Kensler Protection against 2-Hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine Cytotoxicity and DNA Adduct Formation in Human Prostate by Glutathione S-Transferase P1 Cancer Res., January 1, 2001; 61(1): 103 - 109. [Abstract] [Full Text]
|
|
|
|
 |
|
 M-W Yu, C-I Pai, S-Y Yang, T-J Hsiao, H-C Chang, S-M Lin, Y-F Liaw, P-J Chen, and C-J Chen Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk Gut, November 1, 2000; 47(5): 703 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Kulp, M. G. Knize, M. A. Malfatti, C. P. Salmon, and J. S. Felton Identification of urine metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans Carcinogenesis, November 1, 2000; 21(11): 2065 - 2072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. King, C. H. Teitel, and F. F. Kadlubar In vitro bioactivation of N-hydroxy-2-amino-{alpha}-carboline Carcinogenesis, July 1, 2000; 21(7): 1347 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Delfino, R. Sinha, C. Smith, J. West, E. White, H. J. Lin, S.-Y. Liao, J. S.Y. Gim, H. L. Ma, J. Butler, et al. Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype Carcinogenesis, April 1, 2000; 21(4): 607 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhu, A. R. Boobis, and N. J Gooderham The Food-derived Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Activates S-Phase Checkpoint and Apoptosis, and Induces Gene Mutation in Human Lymphoblastoid TK6 Cells Cancer Res., March 1, 2000; 60(5): 1283 - 1289. [Abstract] [Full Text]
|
|
|
|
|
|
D. W. Hein, M. A. Doll, A. J. Fretland, M. A. Leff, S. J. Webb, G. H. Xiao, U.-S. Devanaboyina, N. A. Nangju, and Y. Feng Molecular Genetics and Epidemiology of the NAT1 and NAT2 Acetylation Polymorphisms Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 29 - 42. [Abstract] [Full Text]
|
|
|
|
|
|
S. A.M. Bol, J. Horlbeck, J. Markovic, J. G. de Boer, R. J. Turesky, and A. Constable Mutational analysis of the liver, colon and kidney of Big Blue(R) rats treated with 2-amino-3-methylimidazo[4,5-f]quinoline Carcinogenesis, January 1, 2000; 21(1): 1 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kestell, L. Zhao, S. Zhu, P. J. Harris, and L. R. Ferguson Studies on the mechanism of cancer protection by wheat bran: effects on the absorption, metabolism and excretion of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) Carcinogenesis, December 1, 1999; 20(12): 2253 - 2260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Paladino, B. Weibel, and C. Sengstag Heterocyclic aromatic amines efficiently induce mitotic recombination in metabolically competent Saccharomyces cerevisiae strains Carcinogenesis, November 1, 1999; 20(11): 2143 - 2152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Stillwell, R. J. Turesky, R. Sinha, and S. R. Tannenbaum N-Oxidative Metabolism of 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in Humans Excretion of the N2-Glucuronide Conjugate of 2-Hydroxyamino-MeIQx in Urine Cancer Res., October 1, 1999; 59(20): 5154 - 5159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kimura, M. Kawabe, J. M. Ward, H. Morishima, F. F. Kadlubar, G. J. Hammons, P. Fernandez-Salguero, and F. J. Gonzalez CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice Carcinogenesis, September 1, 1999; 20(9): 1825 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Leff, P. N. Epstein, M. A. Doll, A. J. Fretland, U.-S. Devanaboyina, T. D. Rustan, and D. W. Hein Prostate-Specific Human N-Acetyltransferase 2 (NAT2) Expression in the Mouse J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 182 - 187. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. D. Potter Colorectal Cancer: Molecules and Populations J Natl Cancer Inst, June 2, 1999; 91(11): 916 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Nowell, J. S. Massengill, S. Williams, A. Radominska-Pandya, T. R. Tephly, Z. Cheng, C. P. Strassburg, R. H. Tukey, S. L. MacLeod, N. P. Lang, et al. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved Carcinogenesis, June 1, 1999; 20(6): 1107 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A.J. Schut and E. G. Snyderwine DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis Carcinogenesis, March 1, 1999; 20(3): 353 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sinha and N. Caporaso Diet, Genetic Susceptibility and Human Cancer Etiology J. Nutr., February 1, 1999; 129(2): 556 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Davis, Y. Feng, D. W. Hein, and J. W. Finley The Chemical Form of Selenium Influences 3,2'-Dimethyl-4-aminobiphenyl-DNA Adduct Formation in Rat Colon J. Nutr., January 1, 1999; 129(1): 63 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Dingley, S. P. H. T. Freeman, D. O. Nelson, R. C. Garner, and K. W. Turteltaub Covalent Binding of 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline to Albumin and Hemoglobin at Environmentally Relevant Doses. Comparison of Human Subjects and F344 Rats Drug Metab. Dispos., August 1, 1998; 26(8): 825 - 828. [Abstract] [Full Text]
|
|
|
|
|
|
B. Clement and M. Demesmaeker Formation of Guanoxabenz from Guanabenz in Human Liver. A new metabolic marker for CYP1A2 Drug Metab. Dispos., November 1, 1997; 25(11): 1266 - 1271. [Abstract] [Full Text]
|
|
|
|
|
|
V. M. Lakshmi, T. V. Zenser, and B. B. Davis Rat Liver Cytochrome P450 Metabolism of N-Acetylbenzidine and N,N'-Diacetylbenzidine Drug Metab. Dispos., April 1, 1997; 25(4): 481 - 488. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. S. Solomon, P.-M. L. Morgenthaler, R. J. Turesky, and J. M. Essigmann Mutational and DNA Binding Specificity of the Carcinogen 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline J. Biol. Chem., August 2, 1996; 271(31): 18368 - 18374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Poster Session Toxicol Pathol, November 1, 1993; 21(6): 623 - 646. [PDF]
|
|